4.5 Review

Stringent response protein as a potential target to intervene persistent bacterial infection

期刊

BIOCHIMIE
卷 165, 期 -, 页码 67-75

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biochi.2019.07.006

关键词

Persistent infection; Stringent response; ppGpp; ppGpp synthetase; RelA; Drug target

资金

  1. Science and Engineering Research Board (SERB), Government of India [SB/YS/LS-176/2014]
  2. ICGEB core funds
  3. ICGEB Arturo Falaschi pre-doctoral fellowship

向作者/读者索取更多资源

More than half of the world's population is infected with persistent bacterial infections, consequently, persisters are gradually becoming a major public health concern. During the persistent phase, bacterial pathogens deploy many regulatory strategies to compensate unfavorable host environmental conditions. The stringent response is one of such gene regulatory mechanisms which is stimulated by nutrient starvation. It is regulated by the synthesis of highly phosphorylated signaling nucleotides, (p) ppGpp or alarmone. (p) ppGpp is synthesized by ppGpp synthetases, and these proteins are classified as RelA/SpoT homolog (RSH) proteins. Subsequently, (p) ppGpp modulate several molecular and biochemical processes ranging from transcription to metabolism. Imperativeness of (p) ppGpp synthetases has been investigated by numerous approaches including microbiology and animal studies, thereby establishing that Rel enzyme deleted strains of pathogenic bacteria were unable to transform in persister form. In this review, we summarize recent findings to corroborate the rationality to consider (p) ppGpp synthetase as a potential target in discovering a novel class of antimicrobial agents to combat persistent infections. Moreover, inhibition studies on Mycobacterium tuberculosis (p) ppGpp synthetase shows that these inhibitors prevent dormant state transition and biofilm formation. Also, we have highlighted the structural biology of (p) ppGpp synthetases, which may provide significant information that could be used in structure-based inhibitor design. (C) 2019 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据